Trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2 (ERBB2)-mutant (HER2m) metastatic nonesmall cell lung cancer (NSCLC) with and without brain metastases (BMs): Pooled analyses from DESTINY-Lung01 and DESTINY-Lung02

被引：13

作者：

Li, B. T. ^{[1
]}

Planchard, D. ^{[2
]}

Goto, K. ^{[3
]}

Smit, E. F. ^{[4
]}

De langen, J. ^{[5
]}

Goto, Y. ^{[6
]}

Ninomiya, K. ^{[7
]}

Kubo, T. ^{[8
]}

Perol, M. ^{[9
]}

Felip, E. ^{[10
]}

Hayashi, H. ^{[11
]}

Nakagawa, K. ^{[11
]}

Shimizu, J. ^{[12
]}

Nagasaka, M. ^{[13
]}

Pereira, K. M. C. ^{[14
]}

Taguchi, A. ^{[15
]}

Ali, A. ^{[16
]}

Karnoub, M.

Yonemochi, R. ^{[14
]}

Janne, P. A. ^{[17
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Med, New York, NY USA

[2] Gustave Roussy, Med Oncol, Villejuif, France

[3] Natl Canc Ctr Hosp East, Dept Thorac Oncol, Kashiwa, Chiba, Japan

[4] LUMC Leiden Univ, Dept Pulm Dis, Med Ctr, Leiden, Netherlands

[5] Netherlands Canc Inst, Dept Thorac Oncol, Amsterdam, Netherlands

[6] Natl Canc Ctr, Thorac Oncol, Tokyo, Japan

[7] Okayama Univ Hosp, Ctr Comprehens Genom Med, Okayama, Japan

[8] Okayama Univ Hosp, Ctr Clin Oncol, Okayama, Japan

[9] Leon Berard Canc Ctr, Med Oncol, Lyon, France

[10] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain

[11] Kindai Univ Hosp, Dept Med Oncol, Osakasayama, Japan

[12] Aichi Canc Ctr Hosp, Thorac Oncol, Nagoya, Aichi, Japan

[13] Univ Calif Irvine, Med, Sch Med, Orange, CA USA

[14] Daiichi Sankyo Inc, Oncol, Basking Ridge, NJ USA

[15] Daiichi Sankyo Co Ltd, Clin Dev, Chuo Ku, Tokyo, Japan

[16] Dauchi Sankyo Europe GmbH, Global Oncol Med Affairs, Munich, Germany

[17] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA USA

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.09.2354

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

1321MO

引用

页数：2

共 50 条

[41] Exposure-response (ER) analyses of efficacy and safety of trastuzumab deruxtecan (T-DXd) to inform dosing recommendation in HER2-mutant non-small cell lung cancer (NSCLC) [J].

Khatri, Amit ;

Polhamus, Daniel ;

Cobbina, Enoch ;

Garcia, Ramon ;

Yoder, Todd ;

Abutarif, Malaz ;

Garimella, Tushar .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

[42] A phase Ib dose-escalation study evaluating trastuzumab deruxtecan (T-DXd) and durvalumab in combination with chemotherapy as first-line treatment in patients with advanced or metastatic nonsquamous non-small cell lung cancer (NSCLC) and HER2 overexpression (DESTINY-Lung03) [J].

Planchard, D. ;

Yang, J. C-H. ;

Brahmer, J. R. ;

Ragone, A. ;

Chen, J. ;

Liu, F. ;

Saggese, M. .

JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (04) :S798-S798

[43] Efficacy and safety of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: Results from the bladder cohort of the DESTINY-PanTumor02 (DP-02) study [J].

Wysocki, Piotr Jan ;

Jung, Kyung Hae ;

Oh, Do-Youn ;

Doroshow, Deborah Blythe ;

Artamonova, Elena ;

Mammatas, Lemonitsa ;

Su, Po-Jung ;

Moiseyenko, Vladimir ;

Penkov, Konstantin ;

Stroyakovskiy, Daniil ;

Bartolome, Jorge ;

Siena, Salvatore ;

Fielding, Anitra ;

Jung, Lindsey ;

Michelini, Flavia ;

Puvvada, Soham D. ;

Makker, Vicky .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

[44] Analysis of study drug-related interstitial lung disease (ILD) in patients (pts) with HER2+metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd) [J].

Powell, C. A. ;

Modi, S. ;

Iwata, H. ;

Takahashi, S. ;

Nie, K. ;

Qin, A. ;

Singh, J. ;

Taitt, C. ;

Verma, S. ;

Camidge, D. R. .

ANNALS OF ONCOLOGY, 2021, 32 :S61-S62

[45] Real world data on Trastuzumab Deruxtecan (T-DXd) induced Interstitial Lung disease (ILD) in HER2 positive metastatic breast cancer patients at the Kent Oncology Centre [J].

Mohammed, S. ;

Moss, C. ;

Harper-Wynne, C. .

CLINICAL ONCOLOGY, 2025, 38

[46] Trastuzumab deruxtecan (T-DXd) vs trastuzumab emtansine (T-DM1) in patients (pts) with HER2+metastatic breast cancer (mBC): Updated survival results of DESTINY-Breast03 [J].

Hamilton, Erika P. ;

Hurvitz, Sara A. ;

Im, Seock-Ah ;

Iwata, Hiroji ;

Curigliano, Giuseppe ;

Kim, Sung-Bae ;

Chiu, Joanne Wing-Yan ;

Pedrini, Jose Luiz ;

Li, Wei ;

Yonemori, Kan ;

Bianchini, Giampaolo ;

Loi, Sherene ;

Borges, Giuliano Santos ;

Wang, Xian ;

Bachelot, Thomas ;

Nakatani, Shunsuke ;

Ashfaque, Shahid ;

Liang, Zhengkang ;

Egorov, Anton ;

Cortes, Javier .

JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)

[47] An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2 [J].

Lee, J-Y ;

Makker, V. ;

Oaknin, A. ;

Oh, D-Y ;

Anoka, C. ;

Jung, L. ;

Simoes, J. ;

Puvvada, S. D. ;

Meric-Bernstam, F. .

ANNALS OF ONCOLOGY, 2024, 35 :S1553-S1553

[48] Trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC): Final results from a phase 2, multicenter, open-label study (DESTINY-CRC01) [J].

Yoshino, Takayuki ;

Di Bartolomeo, Maria ;

Raghav, Kanwal Pratap Singh ;

Masuishi, Toshiki ;

Kawakami, Hisato ;

Yamaguchi, Kensei ;

Nishina, Tomohiro ;

Wainberg, Zev A. ;

Elez, Elena ;

Rodriguez, Javier ;

Fakih, Marwan ;

Ciardiello, Fortunato ;

Saxena, Kapil ;

Kobayashi, Kojiro ;

Bako, Emarjola ;

Okuda, Yasuyuki ;

Meinhardt, Gerold ;

Grothey, Axel ;

Siena, Salvatore .

JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (04)

[49] An open-label, multicenter, phase II study of trastuzumab deruxtecan (T-DXd) in patients (pts) with HER2-expressing solid tumors: DESTINY-PanTumor02 (DP-02) part 2 [J].

Lee, J-Y. ;

Makker, V. ;

Oaknin, A. ;

Oh, D-y. ;

Anoka, C. ;

Jung, L. ;

Simoes, J. ;

Puvvada, S. D. ;

Meric-Bernstam, F. .

ANNALS OF ONCOLOGY, 2024, 35

[50] A phase II, multicenter, open-label study of trastuzumab deruxtecan (T-DXd; DS-8201) in patients (pts) with HER2-expressing metastatic colorectal cancer (mCRC): DESTINY-CRC01. [J].

Siena, Salvatore ;

Di Bartolomeo, Maria ;

Raghav, Kanwal Pratap Singh ;

Masuishi, Toshiki ;

Loupakis, Fotios ;

Kawakami, Hisato ;

Yamaguchi, Kensei ;

Nishina, Tomohiro ;

Fakih, Marwan ;

Elez, Elena ;

Rodriguez, Javier ;

Ciardiello, Fortunato ;

Saxena, Kapil ;

Yamamoto, Eriko ;

Bako, Emarjola ;

Okuda, Yasuyuki ;

Shahidi, Javad ;

Grothey, Axel ;

Yoshino, Takayuki .

JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)

← 1 2 3 4 5 →